False
March 25, 2026
Fabrice Gritti spent a year immersed in the world of DNA physics to resurrect a long-abandoned technique to solve modern challenges in cell and gene therapy analysis
6 min read
March 13, 2026
Why early, risk-based thinking is critical in cell and gene therapy development
5 min read
March 12, 2026
ReiThera’s leaders discuss platform technologies, scalable manufacturing, and the trust needed to strengthen global vaccine preparedness
5 min read
By Stephanie Vine
March 10, 2026
Corporate compliance isn’t just about avoiding fines; it’s an opportunity to shape culture, partnerships, and everyday decision-making
10 min read
March 3, 2026
Exploring new applications for KinetiSol and the evolving role of CDMOs in bringing the next generation of complex molecules to patients
4 min read
February 25, 2026
A Q&A with iXCells Biotechnologies CEO, Steve Smith
8 min read
February 24, 2026
KinetiSol’s solvent-free mixing process turns “brick dust” drugs into stable amorphous dispersions
5 min read
February 23, 2026
An Interview with Adam Davenport, CSO, Concept Life Sciences
4 min read
February 18, 2026
Greg Thomas, Kiel Laboratories’ Vice President of R&D, discusses oral suspensions, excipients, and patient-centered formulation
4 min read
February 12, 2026
Why immersive training could be critical to closing the UK’s medicines manufacturing skills gap
4 min read
False